Skip to main content

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Govt to constitute National Apex Committee for monitoring stem cell research soon

    Almost two years after announcing the Guidelines for Stem Cell Research Regulation, prescribing stringent procedures for souring and use of stem cells by research institutions in the country, the union health ministry is yet to constitute the National Apex Committee (NAC) for effectively reviewing and monitoring the stem cell research in the country.

  • INTERPHEX Asia to be held in Singapore on June 7

    INTERPHEX Asia, a platform for showcasing latest technologies and expertise to the pharmaceutical and biopharmaceutical industry players in Asia will be held at Suntec International Convention & Exhibition Centre , Singapore on June 7 & 8, 2010.

  • US FDA approves velaglucerase alfa for injection to treat rare genetic disorder Gaucher disease

    The US Food and Drug Administration has approved velaglucerase alfa for injection (VPRIV) to treat children and adults with a form of the rare genetic disorder Gaucher disease.

    Gaucher disease occurs in people who do not produce enough of an enzyme called glucocerebrosidase. Without this enzyme, harmful amounts of a certain fatty substance (lipid) can build up in the liver, spleen, bones, bone marrow and nervous system, and can prevent cells and organs from working properly. About one in 50,000 to one in 100,000 people in the general population have Gaucher disease.

  • MakroCare to organise Webinar on Late Phase (PMS & IIT) on March 5

    MakroCare, a global clinical services firm which provides clinical research support to pharmaceutical, biotechnology and medical devices industries will be organising an interactive “Webinar on Late Phase (PMS and IIT) – Opportunities and Challenges” on March 5, 2010 at Makro Tower, Hyderabad from 3.00 p.m. to 04.30 p.m.

Subscribe to Pharma News